UK markets close in 3 hours 18 minutes

RBC Life Sciences, Inc. (RBCL)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.07710.0000 (0.00%)
At close: 2:36PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5170.62k
Enterprise value 3-1.92M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)0.01
Price/book (mrq)0.02
Enterprise value/revenue 3-0.08
Enterprise value/EBITDA 71.07

Trading information

Stock price history

Beta (5Y monthly) 0.14
52-week change 3-33.33%
S&P500 52-week change 338.50%
52-week high 30.2600
52-week low 30.0700
50-day moving average 30.0853
200-day moving average 30.1087

Share statistics

Avg vol (3-month) 350
Avg vol (10-day) 333
Shares outstanding 52.21M
Implied shares outstanding 6N/A
Float N/A
% held by insiders 18.31%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 311 Aug 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2014
Most-recent quarter (mrq)29 Sept 2015

Profitability

Profit margin -2.32%
Operating margin (ttm)-9.60%

Management effectiveness

Return on assets (ttm)-10.03%
Return on equity (ttm)-6.77%

Income statement

Revenue (ttm)24.12M
Revenue per share (ttm)10.90
Quarterly revenue growth (yoy)-28.10%
Gross profit (ttm)15.64M
EBITDA -1.79M
Net income avi to common (ttm)-559.51k
Diluted EPS (ttm)-0.2530
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.09M
Total cash per share (mrq)0.94
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)2.16
Book value per share (mrq)3.63

Cash flow statement

Operating cash flow (ttm)-2.9M
Levered free cash flow (ttm)-2.59M